243 results on '"Kainov, Denis E."'
Search Results
2. The combination of pleconaril, rupintrivir, and remdesivir efficiently inhibits enterovirus infections in vitro, delaying the development of drug-resistant virus variants
3. Combating pan-coronavirus infection by indomethacin through simultaneously inhibiting viral replication and inflammatory response
4. Seven classes of antiviral agents
5. Ivermectin effectively inhibits hepatitis E virus replication, requiring the host nuclear transport protein importin α1
6. Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with endemic human coronaviruses
7. Discovery and development of safe-in-man broad-spectrum antiviral agents
8. Boosted production of antibodies which neutralized different SARS-CoV-2 variants in a COVID-19 convalescent following mRNA vaccination – a case study
9. Antiviral Immunoglobulins of Chicken Egg Yolk for Potential Prevention of SARS-CoV-2 Infection
10. Novel Synergistic Anti-Enteroviral Drug Combinations
11. Mono- and combinational drug therapies for global viral pandemic preparedness
12. Recapitulating hepatitis E virus-host interactions and facilitating antiviral drug discovery in human liver-derived organoids
13. Obatoclax, saliphenylhalamide and gemcitabine inhibit Zika virus infection in vitro and differentially affect cellular signaling, transcription and metabolism
14. Regulation of kynurenine biosynthesis during influenza virus infection
15. DrugVirus.info 2.0: an integrative data portal for broad-spectrum antivirals (BSA) and BSA-containing drug combinations (BCCs)
16. Mono- and combinational drug therapies for global viral pandemic preparedness
17. Broad-Spectrum Antivirals and Antiviral Drug Combinations
18. Recapitulating hepatitis E virus–host interactions and facilitating antiviral drug discovery in human liver–derived organoids
19. Broad-spectrum mono- and combinational drug therapies for global viral pandemic preparedness
20. Synergistic Interferon-Alpha-Based Combinations for Treatment of SARS-CoV-2 and Other Viral Infections
21. Nafamostat–Interferon-α Combination Suppresses SARS-CoV-2 Infection In Vitro and In Vivo by Cooperatively Targeting Host TMPRSS2
22. Boosted production of antibodies that neutralized different SARS-CoV-2 variants in a COVID-19 convalescent following messenger RNA vaccination - a case study
23. Nafamostat-interferon-alpha combination suppresses SARS-CoV-2 infection by targeting cooperatively host TMPRSS2 in vitro and in vivo
24. Screening of FDA-Approved Drugs Using a MERS-CoV Clinical Isolate from South Korea Identifies Potential Therapeutic Options for COVID-19
25. A method to identify physical, chemical and biological factors that trigger Bcl-xL-mediated apoptosis
26. Drug candidates for treatment of China 2019-nCoV coronavirus
27. Synergistic Interferon Alpha-based Drug Combinations Inhibit SARS-CoV-2 and other viral Infections in Vitro
28. DNA Damage Response
29. Interferon alpha-based combinations suppress SARS-CoV-2 infection in vitro and in vivo
30. Drug screening identified gemcitabine inhibiting hepatitis E virus by inducing interferon-like response via activation of STAT1 phosphorylation
31. The proton translocation domain of cellular vacuolar ATPase provides a target for the treatment of influenza A virus infections
32. Identification and Tracking of Antiviral Drug Combinations
33. Drug screening identifies gemcitabine inhibiting rotavirus through alteration of pyrimidine nucleotide synthesis pathway
34. Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with an endemic human CoV
35. Chemical, Physical and Biological Triggers of Evolutionary Conserved Bcl-xL-Mediated Apoptosis
36. Potential Antiviral Options against SARS-CoV-2 Infection
37. Screening of FDA-approved drugs using a MERS-CoV clinical isolate from South Korea identifies potential therapeutic options for COVID-19
38. Discovery and Development of Safe-in-Man Broad-Spectrum Antiviral Agents
39. Discovery and Development of Safe-in-Man Broad-Spectrum Antiviral Agents
40. Low Temperature and Low UV Indexes Correlated with Peaks of Influenza Virus Activity in Northern Europe during 2010-2018
41. Novel Antiviral Activities of Obatoclax, Emetine, Niclosamide, Brequinar, and Homoharringtonine
42. Packaging motor from double-stranded RNA bacteriophage φ12 acts as an obligatory passive conduit during transcription
43. Novel Antiviral Activities of Obatoclax, Emetine, Niclosamide, Brequinar, and Homoharringtonine
44. Single Passage of Human Metapneumovirus in LLC-MK2 Cells Does Not Affect Viral Protein-Coding Capacity
45. Antiviral Properties of Chemical Inhibitors of Cellular Anti-Apoptotic Bcl-2 Proteins
46. Multi-Omics Studies towards Novel Modulators of Influenza A Virus-Host Interaction
47. Influenza Virus Infection, Interferon Response, Viral Counter-Response, and Apoptosis
48. Atomic snapshots of an RNA packaging motor reveal conformational changes linking ATP hydrolysis to RNA translocation
49. Regulation of kynurenine biosynthesis during influenza virus infection
50. Multi-Omics Studies towards Novel Modulators of Influenza A Virus-Host Interaction
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.